Literature DB >> 18199617

Gastrin-releasing peptide receptor imaging in human breast carcinoma versus immunohistochemistry.

Christophe Van de Wiele1, Philippe Phonteyne, Patrick Pauwels, Ingeborg Goethals, Rudi Van den Broecke, Veronique Cocquyt, Rudi Andre Dierckx.   

Abstract

UNLABELLED: This study reports on the uptake of (99m)Tc-RP527 by human breast carcinoma and its relationship to gastrin-releasing peptide receptor (GRP-R) expression as measured by immunohistochemistry (IHC).
METHODS: Nine patients referred because of a clinical diagnosis suggestive of breast carcinoma and 5 patients with tamoxifen-resistant bone-mestastasized breast carcinoma underwent (99m)Tc-RP527 scintigraphy. The findings were compared with routine staging examinations in all patients and with routine histology and IHC GRP-R staining in the first 9 patients. All 9 patients with suspected breast lesions were tumor positive.
RESULTS: The uptake of (99m)Tc-RP527 was evident in the primary tumor in 8 of 9 patients and in involved lymph nodes and part of the distant metastasis limited to the bone when present. (99m)Tc-RP527 uptake was not found in any of the tamoxifen-resistant patients.
CONCLUSION: Uptake by primary breast carcinoma was significantly correlated with the presence of GRP-Rs as assessed by means of IHC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18199617     DOI: 10.2967/jnumed.107.047167

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  17 in total

Review 1.  Bombesin receptor-mediated imaging and cytotoxicity: review and current status.

Authors:  Veronica Sancho; Alessia Di Florio; Terry W Moody; Robert T Jensen
Journal:  Curr Drug Deliv       Date:  2011-01       Impact factor: 2.565

Review 2.  Peptides and peptide hormones for molecular imaging and disease diagnosis.

Authors:  Seulki Lee; Jin Xie; Xiaoyuan Chen
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

3.  Clinical Translation of a Dual Integrin αvβ3- and Gastrin-Releasing Peptide Receptor-Targeting PET Radiotracer, 68Ga-BBN-RGD.

Authors:  Jingjing Zhang; Gang Niu; Lixin Lang; Fang Li; Xinrong Fan; Xuefeng Yan; Shaobo Yao; Weigang Yan; Li Huo; Libo Chen; Zhiyuan Li; Zhaohui Zhu; Xiaoyuan Chen
Journal:  J Nucl Med       Date:  2016-08-04       Impact factor: 10.057

4.  (18)F, (64)Cu, and (68)Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer.

Authors:  Zhaofei Liu; Yongjun Yan; Shuanglong Liu; Fan Wang; Xiaoyuan Chen
Journal:  Bioconjug Chem       Date:  2009-05-20       Impact factor: 4.774

Review 5.  Bombesin related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting and treatment.

Authors:  Paola Moreno; Irene Ramos-Álvarez; Terry W Moody; Robert T Jensen
Journal:  Expert Opin Ther Targets       Date:  2016-03-28       Impact factor: 6.902

6.  Identification of a new peptide for fibrosarcoma tumor targeting and imaging in vivo.

Authors:  Chia-Che Wu; Erh-Hsuan Lin; Yu-Ching Lee; Cheng-Jeng Tai; Tsu-Hsiang Kuo; Hsin-Ell Wang; Tsai-Yueh Luo; Ying-Kai Fu; Haw-Jan Chen; Ming-Ding Sun; Chih-Hsiung Wu; Cheng-Wen Wu; Sy-Jye Leu; Win-Ping Deng
Journal:  J Biomed Biotechnol       Date:  2010-12-05

Review 7.  Targeting GRPR in urological cancers--from basic research to clinical application.

Authors:  Rosalba Mansi; Achim Fleischmann; Helmut R Mäcke; Jean C Reubi
Journal:  Nat Rev Urol       Date:  2013-03-19       Impact factor: 14.432

8.  Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [⁶⁸Ga]SB3 and PET/CT.

Authors:  Theodosia Maina; Hendrik Bergsma; Harshad R Kulkarni; Dirk Mueller; David Charalambidis; Eric P Krenning; Berthold A Nock; Marion de Jong; Richard P Baum
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-12-02       Impact factor: 9.236

9.  (68)Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging.

Authors:  Zhaofei Liu; Gang Niu; Fan Wang; Xiaoyuan Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-04-10       Impact factor: 9.236

10.  68Ga-NOTA-Aca-BBN(7-14) PET/CT in Healthy Volunteers and Glioma Patients.

Authors:  Jingjing Zhang; Deling Li; Lixin Lang; Zhaohui Zhu; Ling Wang; Peilin Wu; Gang Niu; Fang Li; Xiaoyuan Chen
Journal:  J Nucl Med       Date:  2015-10-08       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.